Literature DB >> 23634684

Results of surgical excision and evaluation of factors associated with survival time in dogs with lingual neoplasia: 97 cases (1995-2008).

William T N Culp1, Nicole Ehrhart, Stephen J Withrow, Robert B Rebhun, Sarah Boston, Paolo Buracco, Alexander M Reiter, Sandra P Schallberger, Charles F Aldridge, Michael S Kent, Philipp D Mayhew, Dorothy C Brown.   

Abstract

OBJECTIVE: To describe the clinical characteristics, treatments, outcomes, and factors associated with survival time in a cohort of dogs with lingual neoplasia that underwent surgical excision.
DESIGN: Retrospective case series. Animals-97 client-owned dogs. PROCEDURES: Medical records of dogs with a lingual tumor examined between 1995 and 2008 were reviewed. Records were included if a lingual tumor was confirmed by histologic examination and surgical excision of the mass was attempted. Data were recorded and analyzed to identify prognostic factors.
RESULTS: Clinical signs were mostly related to the oral cavity. For 93 dogs, marginal excision, subtotal glossectomy, and near-total glossectomy were performed in 35 (38%), 55 (59%), and 3 (3%), respectively. Surgery-related complications were rare, but 27 (28%) dogs had tumor recurrence. The most common histopathologic diagnoses for the 97 dogs were squamous cell carcinoma (31 [32%]) and malignant melanoma (29 [30%]). Eighteen (19%) dogs developed metastatic disease, and the overall median survival time was 483 days. Median survival time was 216 days for dogs with squamous cell carcinoma and 241 days for dogs with malignant melanoma. Dogs with lingual tumors ≥ 2 cm in diameter at diagnosis had a significantly shorter survival time than did dogs with tumors < 2 cm. CONCLUSIONS AND CLINICAL RELEVANCE: Similar to previous studies, results indicated that lingual tumors are most commonly malignant, and squamous cell carcinoma and malignant melanoma predominate. A thorough physical examination to identify lingual tumors at an early stage and surgical treatment after tumor identification are recommended because tumor size significantly affected survival time.

Entities:  

Mesh:

Year:  2013        PMID: 23634684     DOI: 10.2460/javma.242.10.1392

Source DB:  PubMed          Journal:  J Am Vet Med Assoc        ISSN: 0003-1488            Impact factor:   1.936


  5 in total

Review 1.  Treatment of Canine Oral Melanomas: A Critical Review of the Literature.

Authors:  Paolo Pazzi; Gerhard Steenkamp; Anouska J Rixon
Journal:  Vet Sci       Date:  2022-04-19

2.  Difference in outcome between curative intent vs marginal excision as a first treatment in dogs with oral malignant melanoma and the impact of adjuvant CSPG4-DNA electrovaccination: A retrospective study on 155 cases.

Authors:  Davide Giacobino; Mariateresa Camerino; Federica Riccardo; Federica Cavallo; Lidia Tarone; Marina Martano; Alfredo Dentini; Selina Iussich; Elena Lardone; Paolo Franci; Alberto Valazza; Luca Manassero; Sara Del Magno; Raffaella De Maria; Emanuela Morello; Paolo Buracco
Journal:  Vet Comp Oncol       Date:  2021-03-22       Impact factor: 2.385

3.  Multimodal Treatment of a Canine Lingual Melanoma Using a Combination of Immunotherapy and a Tyrosine Kinase Inhibitors.

Authors:  Alexander Berry; Alison Hayes; Luca Schiavo; Jane Dobson
Journal:  Vet Sci       Date:  2022-01-29

4.  Prolongation of survival of dogs with oral malignant melanoma treated by en bloc surgical resection and adjuvant CSPG4-antigen electrovaccination.

Authors:  L A Piras; F Riccardo; S Iussich; L Maniscalco; F Gattino; M Martano; E Morello; S Lorda Mayayo; V Rolih; F Garavaglia; R De Maria; E Lardone; F Collivignarelli; D Mignacca; D Giacobino; S Ferrone; F Cavallo; P Buracco
Journal:  Vet Comp Oncol       Date:  2016-05-04       Impact factor: 2.613

Review 5.  Proposed Diagnostic Criteria and Classification of Canine Mast Cell Neoplasms: A Consensus Proposal.

Authors:  Michael Willmann; Vilma Yuzbasiyan-Gurkan; Laura Marconato; Mauro Dacasto; Emir Hadzijusufovic; Olivier Hermine; Irina Sadovnik; Susanne Gamperl; Mathias Schneeweiss-Gleixner; Karoline V Gleixner; Thomas Böhm; Barbara Peter; Gregor Eisenwort; Richard Moriggl; Zhixiong Li; Mohamad Jawhar; Karl Sotlar; Erika Jensen-Jarolim; Veronika Sexl; Hans-Peter Horny; Stephen J Galli; Michel Arock; David M Vail; Matti Kiupel; Peter Valent
Journal:  Front Vet Sci       Date:  2021-12-10
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.